These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
921 related articles for article (PubMed ID: 9755927)
21. [Mycobacterium tuberculosis resistance to antitubercular agents in Antananarivo in 2000]. Ratsirahonana O; Rasolofo Razanamparany V; Rasolonavalona T; Rakotonirina V; Rakotoarisaonina A; Rakotoherisoa A; Ralamboson M; Cauchoix B; Rakotondramarina D; Ramarokoto H Arch Inst Pasteur Madagascar; 2002; 68(1-2):44-7. PubMed ID: 12643091 [TBL] [Abstract][Full Text] [Related]
22. Multicenter evaluation of reverse line blot assay for detection of drug resistance in Mycobacterium tuberculosis clinical isolates. Mokrousov I; Bhanu NV; Suffys PN; Kadival GV; Yap SF; Cho SN; Jordaan AM; Narvskaya O; Singh UB; Gomes HM; Lee H; Kulkarni SP; Lim KC; Khan BK; van Soolingen D; Victor TC; Schouls LM J Microbiol Methods; 2004 Jun; 57(3):323-35. PubMed ID: 15134881 [TBL] [Abstract][Full Text] [Related]
23. [Analysis of restriction fragment length polymorphism (RFLP) in epidemiology of tuberculosis]. Gómez Marín JE; Rigouts L; Villegas Londoño LE; Portaels F Bol Oficina Sanit Panam; 1995 Jul; 119(1):1-10. PubMed ID: 7654295 [TBL] [Abstract][Full Text] [Related]
24. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing. Laszlo A; Rahman M; Raviglione M; Bustreo F Int J Tuberc Lung Dis; 1997 Jun; 1(3):231-8. PubMed ID: 9432369 [TBL] [Abstract][Full Text] [Related]
25. Surveillance of Mycobacterium tuberculosis drug resistance in France, 1995-1997. AZAY Mycobacteria Study Group. Robert J; Trystram D; Truffot-Pernot C; Carbonnelle B; Grosset J Int J Tuberc Lung Dis; 2000 Jul; 4(7):665-72. PubMed ID: 10907770 [TBL] [Abstract][Full Text] [Related]
26. Prevalence of initial drug resistance to M. tuberculosis in new sputum positive RNTCP patients. Dhingra VK; Rajpal S; Bhalla P; Yadav A; Jain SK; Hanif M J Commun Dis; 2003 Jun; 35(2):82-9. PubMed ID: 15562953 [TBL] [Abstract][Full Text] [Related]
27. National anti-tuberculosis drug resistance survey, 2002, in Myanmar. Ti T; Lwin T; Mar TT; Maung W; Noe P; Htun A; Kluge HH; Wright A; Aziz MA; Paramasivan CN Int J Tuberc Lung Dis; 2006 Oct; 10(10):1111-6. PubMed ID: 17044203 [TBL] [Abstract][Full Text] [Related]
28. Primary drug resistant tuberculosis in the Central Chest Clinic, Colombo. Perera J; Wijekoon PN; Gamage S Ceylon Med J; 1996 Jun; 41(2):51-4. PubMed ID: 8771943 [TBL] [Abstract][Full Text] [Related]
29. Drug resistance to the first line of antitubercular regimen (a preliminary report). Varaiya A; Gogate A Indian J Public Health; 1998; 42(4):126-30. PubMed ID: 10389525 [TBL] [Abstract][Full Text] [Related]
30. [Treatment results of rifampicin (RFP) resistant isoniazid (INH) susceptible tuberculosis, a hospital based study]. Yoshiyama T; Ogata H; Ito K; Aono A; Wada M Kekkaku; 2007 Feb; 82(2):95-101. PubMed ID: 17373318 [TBL] [Abstract][Full Text] [Related]
31. Drug resistance among Mycobacterium tuberculosis isolates from private clinics and a dots center in Delhi, India. Angrup A; Varma-Basil M; Kumar S; Pathak RK; Sharma H; Banavaliker JN; Bose M Southeast Asian J Trop Med Public Health; 2011 Jan; 42(1):122-7. PubMed ID: 21323174 [TBL] [Abstract][Full Text] [Related]
32. Primary resistance to anti-tuberculosis drugs in Addis Ababa, Ethiopia. Demissie M; Gebeyehu M; Berhane Y Int J Tuberc Lung Dis; 1997 Feb; 1(1):64-7. PubMed ID: 9441061 [TBL] [Abstract][Full Text] [Related]
33. Prevalence of katG Ser315 substitution and rpoB mutations in isoniazid-resistant Mycobacterium tuberculosis isolates from Brazil. Höfling CC; Pavan EM; Giampaglia CM; Ferrazoli L; Aily DC; de Albuquerque DM; Ramos MC Int J Tuberc Lung Dis; 2005 Jan; 9(1):87-93. PubMed ID: 15675556 [TBL] [Abstract][Full Text] [Related]
34. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results]. Fujino T; Hasegawa N; Satou R; Komatsu H; Kawada K Kekkaku; 1998 Jul; 73(7):471-6. PubMed ID: 9739579 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of Mycobacteria Growth Indicator Tube (MGIT) for drug susceptibility testing of Mycobacterium tuberculosis. Palomino JC; Traore H; Fissette K; Portaels F Int J Tuberc Lung Dis; 1999 Apr; 3(4):344-8. PubMed ID: 10206506 [TBL] [Abstract][Full Text] [Related]
36. Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry. Akselband Y; Cabral C; Shapiro DS; McGrath P J Microbiol Methods; 2005 Aug; 62(2):181-97. PubMed ID: 16009276 [TBL] [Abstract][Full Text] [Related]
37. [Resistance of the Koch bacillus to antibacillary agents in the Department of the Lower Rhine]. Cooreman J; Burghard G; Grosset J Rev Fr Mal Respir; 1983; 11(5):699-704. PubMed ID: 6419307 [TBL] [Abstract][Full Text] [Related]
38. Radiometric and conventional drug susceptibility testing of Mycobacterium tuberculosis. Hoel T; Eng J APMIS; 1991 Nov; 99(11):977-80. PubMed ID: 1958354 [TBL] [Abstract][Full Text] [Related]
39. Drug resistant tuberculosis in Estonia. Kruuner A; Sillastu H; Danilovitsh M; Levina K; Svenson SB; Källenius G; Hoffner SE Int J Tuberc Lung Dis; 1998 Feb; 2(2):130-3. PubMed ID: 9562123 [TBL] [Abstract][Full Text] [Related]
40. Drug resistance of Mycobacterium tuberculosis in the Sunamganj District of Bangladesh. Storla DG; Rahim Z; Islam MA; Plettner S; Begum V; Myrvang B; Bjune G; Rønnild E; Dahle UR; Mannsåker T Scand J Infect Dis; 2007; 39(2):142-5. PubMed ID: 17366031 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]